| Friday, September 11, 2009 | ||
| 07:30:00 | Registration and Continental Breakfast | |
| 07:55:00 | Welcome and Introductions | |
| 08:00:00 | Presession Survey | |
| 08:05:00 | Keynote Presentation: From Bench to Bedside in Hematologic Malignancies | Thomas P. Miller |
| 08:10:00 | Clinical Challenges in Lymphoma | Thomas P. Miller |
| 08:35:00 | Clinical Challenges in Low-Grade Lymphoma | John Sweetenham |
| 08:55:00 | Clinical Challenges in DLBCL | Thomas P. Miller |
| 09:15:00 | Clinical Challenges in MCL | André Goy |
| 09:35:00 | Clinical Challenges in TCLs | Barbara Pro |
| 09:55:00 | Panel Discussion | |
| 10:15:00 | Break | |
| 10:20:00 | Debate: Intensive Versus Non-Intensive Therapies in Mantle Cell Lymphoma | |
| 10:20:00 | Controversies in Lymphoma | Thomas P. Miller |
| 10:30:00 | Intensive TBA | |
| 10:50:00 | Non-Intensive | André Goy |
| 11:10:00 | Clinical Challenges in Treating Elderly Patients With DLBCL | John Sweetenham |
| 11:30:00 | Lymphoma Therapy: The Next Decade TBA | |
| 11:50:00 | Postsession Survey and Panel Discussion | |
| 12:10:00 | Break to Serve Lunch | |
| 13:05:00 | Keynote Presentation: Targeting Cancer Stem Cells in Hematologic Malignancies | Farhad Ravandi |
| 13:10:00 | Clinical Challenges in CLL | Stefan Faderl |
| 13:40:00 | Presession Survey | |
| 13:45:00 | Pathologic Subtypes of CLL: Clinical Implications TBA | |
| 14:10:00 | Challenges in Frontline Therapy for CLL TBA | |
| 15:25:00 | Postsession Survey and Case-Based Panel Discussion: Applying Principle to Practice | Stefan Faderl |
| 16:00:00 | Tumor Board: Curbside Consultations | |
| 17:00:00 | Adjourn | |
| Saturday, September 12, 2009 | ||
| 07:00:00 | Continental Breakfast | |
| 07:30:00 | Keynote Presentation: Integrated Therapies: A View From the Bench | Rafael Fonseca |
| 07:35:00 | Clinical Challenges in Myeloma | Sundar Jagannath |
| 08:00:00 | Presession Survey | |
| 08:05:00 | Clinical Problems in Multiple Myeloma (Longitudinal Case) | Sundar Jagannath |
| 08:25:00 | Clinical Issues Arising in Older Patients With MM | Edward Stadtmauer |
| 09:05:00 | Optimizing Thromboprophylaxis With Novel Therapies | Maurizio Zangari |
| 09:25:00 | Management of Relapsed Myeloma | Shaji Kumar |
| 09:45:00 | Panel Discussion | |
| 10:05:00 | Break | |
| 10:10:00 | Controversies in Myeloma | Sundar Jagannath |
| 10:20:00 | Cytogenetics, Prognosis, and New Therapies in MM | Keith Stewart |
| 10:45:00 | Should We Treat MGUS/Smoldering Myeloma? TBA | |
| 11:10:00 | Complete Response and Clinical Benefit | P. Leif Bergsagel |
| 11:35:00 | Timing of Transplant | Shaji Kumar |
| 12:00:00 | Postsession Survey and Panel Discussion | |
| 12:20:00 | Break to Serve Lunch | |
| 13:00:00 | Clinical Challenges in Myeloid Malignancies Moderator: TBA | |
| 13:20:00 | Presession Survey | |
| 13:25:00 | Clinical Challenges in Treating Patients With MPDs | Ruben A Mesa |
| 13:45:00 | Clinical Challenges in Treating Elderly Patients With AML | Harry Erba |
| 14:05:00 | Clinical Challenges in CML Resistant to TKIs | Ruben A Mesa |
| 14:25:00 | Controversies in Treating Patients With Lower-Risk MDS | Harry Erba |
| 14:45:00 | Clinical Challenges in Higher-Risk MDS TBA | |
| 15:15:00 | Postsession Survey and Panel Discussion | |
| 15:35:00 | Adjourn | |
How We Rank